A groundbreaking blood test being studied in Virginia could detect 10 different types of cancer with a single screening, ...

Freenome, a biotechnology company pioneering an early cancer detection platform, today announced an exclusive license agreement with Exact Sciences to advance the commercialization of its colorectal ...

Exact Sciences is paying $75 million for exclusive rights to a blood-based "liquid biopsy" screening test from rival firm Freenome ...

A blood test being studied in Virginia could detect 10 different types of cancer with a single screening, potentially transforming early detection and treatment outcomes.

The blood test, and others like it, have been gaining momentum among doctors who use them to help detect cancers that ...

The single-tier test uses artificial intelligence to accurately detect Lyme disease from the first few weeks of infection ...

HealthDay News — Just under half of patients receiving an abnormal blood-based colorectal cancer screening test result receive a follow-up colonoscopy (FU-CY) within 6 months, according to a study ...

The test, developed in part by Johns Hopkins researchers, will dramatically increase access to early detection and treatment ...

A major Alzheimer’s disease medical group is recommending that specialists may use certain blood tests to help diagnose ...

Despite the indication of a potential risk, people who receive abnormal results on blood-based colorectal screening tests commonly do not receive the follow-up colonoscopy.

The Alzheimer’s Association has issued its first clinical practice guideline on the use of blood tests to help diagnose ...